Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy

Ugur Deligezer1 / Yesim Eralp2 / Ebru E. Akisik3 / Elif Z. Akisik4 / Pinar Saip5 / Erkan Topuz6 / Nejat Dalay7

1Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

2Department of Medical Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

3Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

4Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

5Department of Medical Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

6Department of Medical Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

7Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

Corresponding author: Dr. Ugur Deligezer, Department of Basic Oncology, Oncology Institute, 34390 Capa/Istanbul, Turkey Phone: +90-212-4142434, Fax: +90-212-5348078,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 46, Issue 3, Pages 311–317, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: 10.1515/CCLM.2008.080, February 2008

Publication History

Received:
2007-09-03
Accepted:
2007-11-20
Published Online:
2008-02-06

Abstract

Background: The integrity of circulating cell-free DNA (cf-DNA) in serum or plasma appears to be of diagnostic and prognostic value in cancer. Here, we investigated the dynamics of serum DNA levels and the size distribution of cf-DNA during adjuvant chemotherapy of patients with breast cancer (n=73).

Methods: By evaluating sera taken at the beginning and the end of the adjuvant chemotherapy, variations of serum DNA levels and the size distribution were analyzed, based on quantification of shorter apoptotic and longer non-apoptotic fragments from abundant genomic ALU fragments amplified by quantitative real-time PCR.

Results: The mean DNA level did not change significantly during chemotherapy. However, individual cases revealed considerable variation in the amount of serum DNA. It increased in 43.8% of the patients, whereas it decreased in the remaining majority (56.2%). By calculating a “coefficient of variation” (both decrease and increase) in the level of total DNA and non-apoptotic DNA fragments, we compared the values at the beginning and the end of the therapy. For total DNA, the range was between 1.02- and 26-fold (mean 3.76-fold), whereas for non-apoptotic fragments it ranged from 1.01- to 73-fold (mean 6.9-fold) (p=0.033). In accordance with these findings, the integrity of serum DNA was higher in patients with increasing DNA levels and vice versa.

Conclusions: Our findings suggest that non-apoptotic fragments contribute to a higher degree to the change of the DNA level during adjuvant chemotherapy.

Clin Chem Lab Med 2008;46:311–7.

Keywords: adjuvant therapy; breast cancer; cell-free DNA; serum; size distribution

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, and Barbara Burwinkel
Breast Cancer Research and Treatment, 2014, Volume 146, Number 1, Page 163
[2]
Mariangela Zane, Marco Agostini, Maria Vittoria Enzo, Eric Casal Ide, Paola Del Bianco, Francesca Torresan, Isabella Merante Boschin, Gianmaria Pennelli, Andrea Saccani, Domenico Rubello, Donato Nitti, and Maria Rosa Pelizzo
Biomedicine & Pharmacotherapy, 2013, Volume 67, Number 8, Page 723
[3]
Pâmela Oliveira Delgado, Beatriz Costa A. Alves, Flávia de Sousa Gehrke, Renata Kelly Kuniyoshi, Marcelo Langer Wroclavski, Auro Del Giglio, and Fernando Luiz Affonso Fonseca
Tumor Biology, 2013, Volume 34, Number 2, Page 983
[4]
[5]
Shiyang Pan, Wenying Xia, Qingqing Ding, Yongqian Shu, Ting Xu, Yan Geng, Yachun Lu, Dan Chen, Jian Xu, Fang Wang, Chun Zhao, Peijun Huang, Puwen Huang, Hongbing Shen, Zhibin Hu, and Shan Lu
Biomedicine & Pharmacotherapy, 2012, Volume 66, Number 2, Page 131
[6]
Sandi Kwee, Min-Ae Song, Iona Cheng, Lenora Loo, and Maarit Tiirikainen
Clinical and Translational Science, 2012, Volume 5, Number 1, Page 65
[7]
Klaus Jung, Michael Fleischhacker, and Anja Rabien
Clinica Chimica Acta, 2010, Volume 411, Number 21-22, Page 1611
[8]
Marco Agostini, Salvatore Pucciarelli, Maria Vittoria Enzo, Paola Del Bianco, Marta Briarava, Chiara Bedin, Isacco Maretto, Maria Luisa Friso, Sara Lonardi, Claudia Mescoli, Paola Toppan, Emanuele Urso, and Donato Nitti
Annals of Surgical Oncology, 2011, Volume 18, Number 9, Page 2461
[9]
I. Yu. Strelkova, S. A. Abdullaev, G. P. Snigireva, V. G. Bezlepkin, and A. I. Gaziev
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, Volume 5, Number 1, Page 88
[10]
Yu-Jie Gao, Yu-Juan He, Zai-Lin Yang, Hui-Yuan Shao, Yan Zuo, Yao Bai, Hui Chen, Xian-Chun Chen, Feng-Xian Qin, Shi Tan, Jian Wang, Li Wang, and Ling Zhang
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 11
[11]
Jacqui A Shaw, James Brown, R Charles Coombes, Jimmy Jacob, Rachel Payne, Belinda Lee, Karen Page, Natasha Hava, and Justin Stebbing
Biomarkers in Medicine, 2011, Volume 5, Number 1, Page 87
[12]
Simon R. Corrie, Pavel Sova, Qinghua Feng, Tiffany Blair, Nancy B. Kiviat, and Matt Trau
The Analyst, 2011, Volume 136, Number 4, Page 688
[13]
Bozena Dobrzycka, Slawomir J. Terlikowski, Andrzej Mazurek, Oksana Kowalczuk, Wieslawa Niklinska, Lech Chyczewski, and Marek Kulikowski
International Journal of Cancer, 2010, Volume 127, Number 3, Page 612
[14]
Chao Cheng, Motoko Omura-Minamisawa, Yun Kang, Takamitsu Hara, Izumi Koike, and Tomio Inoue
Cancer Science, 2009, Volume 100, Number 2, Page 303

Comments (0)

Please log in or register to comment.